HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,741-1,752 of 4,505
Device study icon
TerminatedNCT06134661

Accelerated rTMS for Psychomotor Slowing

Official study title

Optimizing rTMS for Psychomotor Slowing in Psychosis (ATMSSlowing) - A 1-week, Non-randomised Clinical Trial of add-on Accelerated Repetitive Transcranial Magnetic Stimulation for Psychomotor Slowing in Psychosis

This study ended early.

In Bern
SchizophreniaDevice studyAges 18–60
Countries
Switzerland
Sponsor
University of Bern
Device study icon
SuspendedNCT05567848

Accelerated TMS in Psychosis

Official study title

Accelerated Transcranial Magnetic Stimulation in Psychotic Disorders

Recruitment is currently suspended.

In Boston
SchizophreniaDevice studyAges 18–65
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Drug study icon
CompletedNCT02504151

Cannabidiol Treatment in people with Early Psychosis

Official study title

Cannabidiol Treatment in Patients With Early Psychosis

This study has finished and is no longer accepting participants.

Multiple locations, including New Haven
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Yale University
Behavioral study icon
CompletedNCT02192593

Computerized Cognitive-Behavioral Therapy for Auditory Hallucinations

Official study title

Randomized Controlled Trial of Computerized Cognitive Behavioral Therapy for Auditory Hallucinations in Persons With Psychosis

This study has finished and is no longer accepting participants.

In Cambridge
SchizophreniaBehavioural studyAges 18–70
Countries
United States
Sponsor
Boston University Charles River Campus
Behavioral study icon
CompletedNCT02131116

Integrated Metacognitive Therapy in First Episode Psychosis

Official study title

An Integrated Metacognitive Approach to Improve Insight and Outcomes in Early Psychosis

This study has finished and is no longer accepting participants.

In Indianapolis
SchizophreniaBehavioural studyAges 18–35
Countries
United States
Sponsor
Indiana University
Drug study icon
TerminatedNCT00734435

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

Official study title

A Proof of Concept, Multi-Center, Randomized, Double-Blind, Parallel, Placebo-Controlled, Study of Zonisamide Sustained Release (SR) 360 mg Versus Placebo in the Prevention of Weight Gain Associated With Olanzapine Therapy for Psychosis

This study ended early.

Multiple locations, including National City
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
Orexigen Therapeutics, Inc
Device study icon
CompletedNCT02131129

rTMS in First Episode Psychosis

Official study title

Cortical Activation and Cognitive Performance During Repetitive Transcranial Magnetic Stimulation in First-Episode Psychosis: A Pilot Study

This study has finished and is no longer accepting participants.

In Indianapolis
SchizophreniaDevice studyAges 18–40
Countries
United States
Sponsor
Indiana University
Behavioral study icon
UnknownNCT06603922

The Personalized Psychological Treatment for Psychosis

Official study title

Towards a Personalized Medicine Approach to Psychological Treatment for Psychosis

Current recruitment status is unconfirmed.

Multiple locations, including Valparaíso
SchizophreniaBehavioural studyAges 18–65
Countries
France, Chile, Germany, + 2 others
Sponsor
Polish Academy of Sciences

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.